Evaluation of residual disease in human leukemias.
D000951:Antigens, Neoplasm / Q000032:analysis; D002455:Cell Division; D002466:Cell Nucleolus / Q000276:immunology; D003114:Colony-Forming Units Assay; D004253:DNA Nucleotidylexotransferase / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000473:pathology / Q000503:physiopathology*; D012330:RNA, Double-Stranded / Q000032:analysis; D012334:RNA, Neoplasm / Q000032:analysis
D000951:Antigens, Neoplasm; D012330:RNA, Double-Stranded; D012334:RNA, Neoplasm; C040391:malignancy-associated nucleolar antigen, human; D004253:DNA Nucleotidylexotransferase